Methenamine Mandelate Delayed-Release Tablets
» Methenamine Mandelate Delayed-Release Tablets contain not less than 95.0 percent and not more than 105.0 percent of the labeled amount of methenamine mandelate (C6H12N4·C8H8O3).
Packaging and storage— Preserve in well-closed containers.
Disintegration 701: 2 hours and 30 minutes, determined as directed under Delayed-release (enteric coated) Tablets.
Other requirements— Delayed-release Tablets respond to the Identification test and meet the requirements for Uniformity of dosage units and Assay under Methenamine Mandelate Tablets.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Behnam Davani, Ph.D., M.B.A.
Senior Scientist
(MDAA05) Monograph Development-Antivirals and Antimicrobials
Reference Standards Lili Wang, Technical Services Scientist
701 Margareth R.C. Marques, Ph.D.
Senior Scientist
(BPC05) Biopharmaceutics05
USP32–NF27 Page 2923